Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of 20% Mannitol and 3% Hypertonic Saline for Cerebral Relaxation
NCT01745081Phase 4Unknown
- Sponsor
- Université de Sherbrooke
- Start
- Sep 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of hypertonic saline in intracranial hypertension (IH), sponsored by Université de Sherbrooke. Status: unknown.
02
Drugs
hypertonic saline
03
Conditions
intracranial hypertension (IH)
Beyond the preview
Go deeper on NCT01745081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01745081.